When a social decision becomes a structuring lever for market access
Electronic medical card for vulnerable uninsured populations
Here is a very concrete social measure recently implemented in Algeria: a digital mechanism that is transforming access to care for the most vulnerable members of society.
In January 2026, the Algerian government launched an electronic medical card for underprivileged people without social insurance coverage and their minor children, enabling them to receive prescribed medicines free of charge, based on an official list approved by the authorities.
( Echorouk Online )
This “Chifa” card / electronic medical card relies on the network of pharmacies contracted with the National Social Insurance Fund for Salaried Workers (CNAS). Beneficiaries can obtain prescribed medicines free of charge in line with an inter-ministerial list, with no limit on the value or the number of medicines per prescription.
( Dzair Tube )
The scheme was officially announced during a government ceremony attended by the ministers responsible for Labour, Solidarity, and Family, as part of a broader set of social reforms aimed at strengthening protection and access to care for vulnerable populations.
( MédiTerranée )
To be eligible, individuals must submit an administrative and medical file to their municipality’s social services. A commission reviews the application before the card is issued and then activated via CNAS.
( MédiTerranée )
This initiative represents a tangible step forward in access to medicines for the most disadvantaged in Algeria, combining digitalization, free access, and expanded therapeutic coverage.
( Echorouk Online )
Beyond its humanitarian impact, this measure sends several strong signals in terms of market access and pharmaceutical policy.
Three key implications to highlight
1) Institutionalizing equity of access
By formally integrating uninsured populations into a structured national scheme, the State expands the scope of “public” demand and reinforces a model of access based on medical need, not only insurance status.
2) Strengthening the public payer’s role as system architect
Defining an eligible medicines list, using contracted pharmacies, and digitizing the pathway strengthens the payer’s ability to steer access, traceability, and budget sustainability.
3) Opening new space for non-promotional partnerships
Such a system creates a favorable environment for “system-building” public–private partnerships, including:
- supporting structured care pathways,
- improving data collection,
- strengthening capabilities (diagnosis, follow-up, training),
- within a strictly compliant, non-commercial framework.
Market access impacts to watch closely
- Expanded coverage scope: broader access for additional patient segments.
- Stronger public steering (eligibility criteria, official list, defined channels): more structured and predictable access.
- Accelerated digitalization: pathway optimization and improved traceability, subject to health-authority oversight.
Market access is not limited to price and reimbursement. It is also built through public policy decisions that redefine the rules of the game, the target populations, and the levers of long-term impact.
By Access Focus